teclistamab,azacitidine,venetoclax,lemzoparlimab
genmab,janssen,Abbvie,roche
['p921', 'majestec-1', 'teclistamab', 'multiple myeloma']
updated efficacy and safety results of teclistamab, a b-cell maturation antigen x cd3 bispecific antibody, in patients with relapsed/refractory multiple myeloma from majestec-1 (p921) #eha2022 
Professor of hematology, Universitary hospital of Sidi Bel Abbés.
Head, Hospitalisation and  Geriatric Unit.